IDEAYA Biosciences Secures Exclusive License for Promising DLL3-Targeting ADC, SHR-4849

IDYA Stock  USD 26.00  0.84  3.34%   
About 54% of Ideaya Biosciences' investors are presently thinking to get in. The analysis of the overall investor sentiment regarding Ideaya Biosciences suggests that some traders are interested. The current market sentiment, together with Ideaya Biosciences' historical and current headlines, can help investors time the market. In addition, many technical investors use Ideaya Biosciences stock news signals to limit their universe of possible portfolio assets.
  
IDEAYA Biosciences Secures Exclusive License for Promising DLL3-Targeting ADC, SHR-4849

Read at kalkinemedia.com
news
  

Ideaya Biosciences Fundamental Analysis

We analyze Ideaya Biosciences' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Ideaya Biosciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Ideaya Biosciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Price To Book

Price To Book Comparative Analysis

Ideaya Biosciences is currently under evaluation in price to book category among its peers. Price to Book (P/B) ratio is used to relate a company book value to its current market price. A high P/B ratio indicates that investors expect executives to generate more returns on their investments from a given set of assets. Book value is the accounting value of assets minus liabilities.

Ideaya Biosciences Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Ideaya Biosciences stock to make a market-neutral strategy. Peer analysis of Ideaya Biosciences could also be used in its relative valuation, which is a method of valuing Ideaya Biosciences by comparing valuation metrics with similar companies.

Peers

Ideaya Biosciences Related Equities

VTYXVentyx Biosciences   16.36   
0%
100.0%
ANABAnaptysBio   9.28   
0%
56.0%
INZYInozyme Pharma   7.72   
0%
47.0%
RNAAvidity Biosciences   7.22   
0%
44.0%
AMLXAmylyx Pharmaceuticals   6.14   
0%
37.0%
SWTXSpringWorks Therapeutics   5.85   
0%
35.0%
ABOSAcumen Pharmaceuticals   2.70   
0%
16.0%
MGTXMeiraGTx Holdings   2.39   
0%
14.0%
SNDXSyndax Pharmaceuticals   2.06   
0%
12.0%
PTGXProtagonist Therapeutics   1.51   
0%
9.0%
TERNTerns Pharmaceuticals   1.41   
0%
8.0%
KROSKeros Therapeutics   1.13   
0%
6.0%
RVMDRevolution Medicines   0.27   
0%
1.0%
DAWNDay One   0.94   
5.0%
0%
MLTXMoonLake Immunotherapeuti   1.07   
6.0%
0%
XFORX4 Pharmaceuticals   1.33   
8.0%
0%
VRNAVerona Pharma   3.34   
20.0%
0%

Complementary Tools for Ideaya Stock analysis

When running Ideaya Biosciences' price analysis, check to measure Ideaya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ideaya Biosciences is operating at the current time. Most of Ideaya Biosciences' value examination focuses on studying past and present price action to predict the probability of Ideaya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ideaya Biosciences' price. Additionally, you may evaluate how the addition of Ideaya Biosciences to your portfolios can decrease your overall portfolio volatility.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account